Literature DB >> 3871677

Impaired production of interleukin-2 after surgery.

T Akiyoshi, F Koba, S Arinaga, S Miyazaki, T Wada, H Tsuji.   

Abstract

The capacity of peripheral blood mononuclear cells (PBM) to produce interleukin-2 (IL-2) was studied serially before and following operation in patients undergoing various surgical procedures. In patients who had major surgery, significant decrease in IL-2 activity was observed 1, 3 and 6 days after operation as compared to that before surgery, although there was no significant change throughout the post-operative course in patients undergoing minor surgery. IL-2 activity returned to the pre-operative level by the 8th post-operative day. However, it remained significantly depressed 8 days after surgery in patients who had undergone major surgical procedures of more increasing severity. Distribution of T cell subsets, especially OKT4 positive cells, did not differ significantly from the pre-operative value throughout the post-operative course. However, the depressed production of IL-2 3 days after surgery could be abolished when adherent cells were removed from PBM by plastic adherence procedures. These results indicated that adherent cells, but not quantitative change in T cell subsets, might be responsible for the depression of IL-2 production after surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871677      PMCID: PMC1577157     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Immunodepression after major surgery in normal patients.

Authors:  M S Slade; R L Simmons; E Yunis; L J Greenberg
Journal:  Surgery       Date:  1975-09       Impact factor: 3.982

2.  Postoperative depression of the lymphocyte response to phytohaemagglutinin.

Authors:  P R Riddle; M C Berenbaum
Journal:  Lancet       Date:  1967-04-08       Impact factor: 79.321

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Depression of the generation of cell-mediated cytotoxicity by suppressor cells after surgery.

Authors:  S Miyazaki; T Akiyoshi; S Arinaga; F Koba; T Wada; H Tsuji
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

5.  Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.

Authors:  J A Roth; S H Golub; E A Grimm; F R Eilber; D L Morton
Journal:  Surgery       Date:  1976-01       Impact factor: 3.982

6.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Absolute requirement for adherent cells in the production of human interleukin 2 (IL2).

Authors:  J R Neefe; G R Curl; J N Woody
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

8.  TCGF production for cloning and growth of functional human T lymphocytes.

Authors:  H Inouye; J A Hank; B J Alter; F H Bach
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved.

Authors:  E L Reinherz; P C Kung; J M Breard; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

10.  Effect of interleukin 1 on human thymocytes and purified human T cells.

Authors:  A L Maizel; S R Mehta; R J Ford; L B Lachman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  9 in total

1.  Spontaneous Ig secretion and DNA synthesis in lymphoblastoid B cells appearing after surgery.

Authors:  F Di Padova; M Dürig
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

2.  Appearance of spontaneously Ig secreting B cells in human peripheral blood after surgery.

Authors:  F Di Padova; C Di Padova; P Rovagnati; R Tritapepe
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

3.  Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.

Authors:  Jarrod D Predina; Brendan Judy; Veena Kapoor; Aaron Blouin; Louis A Aliperti; Daniel Levine; Olugbenga T Okusanya; Jon Quatromoni; Zvi G Fridlender; Sunil Singhal
Journal:  Am J Transl Res       Date:  2012-04-10       Impact factor: 4.060

4.  Alternations of surface antigens on leukocytes after severe injury: correlation with infectious complications.

Authors:  H C Shih; C H Su; C H Lee
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

5.  Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients.

Authors:  Luca Degrate; Cinzia Nobili; Claudio Franciosi; Roberto Caprotti; Fernando Brivio; Fabrizio Romano; Biagio Eugenio Leone; Rosangela Trezzi; Franco Uggeri
Journal:  Langenbecks Arch Surg       Date:  2008-08-01       Impact factor: 3.445

6.  Tumor growth after laparotomy or laparoscopy. A preliminary study.

Authors:  J D Allendorf; M Bessler; M L Kayton; R L Whelan; M R Treat; R Nowygrod
Journal:  Surg Endosc       Date:  1995-01       Impact factor: 4.584

7.  In vitro effect of interleukin 2 on depression of cell-mediated immune response after surgery.

Authors:  T Akiyoshi; F Koba; S Arinaga; T Wada; H Tsuji
Journal:  Jpn J Surg       Date:  1985-09

8.  Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2.

Authors:  M L Rodrick; J J Wood; J B O'Mahony; C F Davis; J T Grbic; R H Demling; N M Moss; I Saporoschetz; A Jordan; P D'Eon
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

9.  Isoflurane decreases interleukin-2 production by increasing c-Cbl and Cbl-b expression in rat peripheral blood mononuclear cells.

Authors:  Ji Won Choi; Byung Seop Shin
Journal:  J Int Med Res       Date:  2018-06-24       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.